Qiagen (QGEN) Cost of Revenue (2009 - 2025)

Qiagen has disclosed Cost of Revenue across 17 years of filings, most recently posting $200.2 million for Q4 2025.

• Cost of Revenue for Q4 2025 came in at $200.2 million, up 14.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $748.6 million (down 22.63% YoY), and the FY2025 annual result was $790.5 million, up 75.31% from the prior year.
• Cost of Revenue came in at $200.2 million for Q4 2025 at Qiagen, up from $187.8 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $461.6 million in Q2 2024 to a low of $151.7 million in Q1 2024.
• The 5-year median for Cost of Revenue is $177.0 million (2023), against an average of $191.2 million.
• Across the five-year window, Cost of Revenue jumped 177.0% in 2024 and slumped 56.83% in 2025, its largest moves.
• Qiagen's Cost of Revenue stood at $193.1 million in 2021, then fell by 14.33% to $165.5 million in 2022, then grew by 6.98% to $177.0 million in 2023, then dropped by 1.48% to $174.4 million in 2024, then advanced by 14.82% to $200.2 million in 2025.
• The last three Cost of Revenue figures came in at $200.2 million (Q4 2025), $187.8 million (Q3 2025), and $199.3 million (Q2 2025), per Business Quant data.